Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 11 for "Poly(ADP-ribose)" Polymerase Inhibitors
  1. ... Niraparib is in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer cells.
  2. ... Rucaparib is in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer cells.
  3. ... Talazoparib is in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by stopping or slowing the growth ...
  4. ... Niraparib is in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer cells. Abiraterone is ...
  5. Ovarian Cancer/Treatments and Therapies ... Ovarian Cancer ... Treatment of ovarian epithelial, fallopian tube, and primary peritoneal cancers depend on the stage. ...
  6. Ovarian Cancer/Specifics ... Ovarian Cancer ... National Cancer Institute ... Treatment of ovarian epithelial, fallopian tube, and primary peritoneal cancers depend ...
  7. Ovarian Cancer/Diagnosis and Tests ... Ovarian Cancer ... National Cancer Institute ... From the National Institutes of Health ... Treatment of ovarian epithelial, fallopian ...
  8. Ovarian Cancer/Treatments and Therapies ... Ovarian Cancer ... National Cancer Institute ... From the National Institutes of Health ... Treatment of ovarian epithelial, fallopian ...
  9. Ovarian Cancer/Treatments and Therapies ... Ovarian Cancer ... National Cancer Institute ... From the National Institutes of Health ... Treatment of ovarian epithelial, fallopian ...
  10. Ovarian Cancer/Treatments and Therapies ... Ovarian Cancer ... National Cancer Institute ... From the National Institutes of Health ... Treatment of ovarian epithelial, fallopian ...
previous · 1 · 2 · next